{"title":"(溃疡性肿瘤。15例手术切除病例分析[j]。","authors":"E Santoro, M Sacchi, F Carboni, R Santoro","doi":"10.1016/s0001-4001(99)80055-5","DOIUrl":null,"url":null,"abstract":"<p><strong>Study aim: </strong>Klatskin tumors are rare. Prognosis is still poor, and long term survival can be expected only after surgery, which is the treatment of choice. The aim of this study is to report the results of 15 resected cases and, by analysis of the literature, to emphasize the progress of the surgical treatment in hilar cholangiocarcinoma.</p><p><strong>Patients and methods: </strong>Between 1990 and 1998, 27 patients affected by Klatskin tumor were observed. Eight women and seven men underwent surgical resection. The mean age was 59 years. Thirteen patients (48%) had curative resection (7 hilar resection (HR), 5 HR combined with partial hepatectomy (PH) and 1 HR + PH with portal vein resection). Two patients had palliative resection and surgical drainage.</p><p><strong>Results: </strong>One in-hospital death occurred right after hepatectomy with portal vein resection (6.6%). Postoperative morbidity was 40%. Patients were regularly followed. Ten patients died and 5 were alive at the time of this study. The 1, 2 and 3-year survival after a curative resection was 84%, 54% and 34%. The median survival was 28.5 months. Lymph node involvement did not show a statistically significant difference on median survival between the positive group and the negative group (26.2 vs 29.8 months) because of the small number of patients. Survival after hilar resection at 1, 2, 3, and 5 years was 100%, 57.1%, 28.6% and 0%. Four out of the 6 patients who underwent hilar resection combined with partial hepatectomy were still alive 1, 23, 29, 38 months after resection. Hepatectomy increased mortality (16% vs 0%). Palliative biliary resection and surgical drainage were successfully performed in 2 patients.</p><p><strong>Conclusion: </strong>Aggressive surgical treatment of Klatskin tumor can improve the survival of patients. Careful pre-operative management has to be carried out by a multidisciplinary approach including surgeons, hepatologists, radiologists and pathologists. Hepatic resection including the caudate lobe is often performed in order to obtain microscopic tumor-free margins and curative resection (R0). Biliary drainage and treatment of cholangitis is mandatory before surgery in order to improve the surgical outcome. Surgical treatment is characterized by high technical difficulties, and better results can be achieved by hepatobiliary surgical teams.</p>","PeriodicalId":10182,"journal":{"name":"Chirurgie; memoires de l'Academie de chirurgie","volume":"124 2","pages":"132-9; discussion 139-40"},"PeriodicalIF":0.0000,"publicationDate":"1999-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"[Klatskin tumor. A study of 15 resected cases].\",\"authors\":\"E Santoro, M Sacchi, F Carboni, R Santoro\",\"doi\":\"10.1016/s0001-4001(99)80055-5\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Study aim: </strong>Klatskin tumors are rare. Prognosis is still poor, and long term survival can be expected only after surgery, which is the treatment of choice. The aim of this study is to report the results of 15 resected cases and, by analysis of the literature, to emphasize the progress of the surgical treatment in hilar cholangiocarcinoma.</p><p><strong>Patients and methods: </strong>Between 1990 and 1998, 27 patients affected by Klatskin tumor were observed. Eight women and seven men underwent surgical resection. The mean age was 59 years. Thirteen patients (48%) had curative resection (7 hilar resection (HR), 5 HR combined with partial hepatectomy (PH) and 1 HR + PH with portal vein resection). Two patients had palliative resection and surgical drainage.</p><p><strong>Results: </strong>One in-hospital death occurred right after hepatectomy with portal vein resection (6.6%). Postoperative morbidity was 40%. Patients were regularly followed. Ten patients died and 5 were alive at the time of this study. The 1, 2 and 3-year survival after a curative resection was 84%, 54% and 34%. The median survival was 28.5 months. Lymph node involvement did not show a statistically significant difference on median survival between the positive group and the negative group (26.2 vs 29.8 months) because of the small number of patients. Survival after hilar resection at 1, 2, 3, and 5 years was 100%, 57.1%, 28.6% and 0%. Four out of the 6 patients who underwent hilar resection combined with partial hepatectomy were still alive 1, 23, 29, 38 months after resection. Hepatectomy increased mortality (16% vs 0%). Palliative biliary resection and surgical drainage were successfully performed in 2 patients.</p><p><strong>Conclusion: </strong>Aggressive surgical treatment of Klatskin tumor can improve the survival of patients. Careful pre-operative management has to be carried out by a multidisciplinary approach including surgeons, hepatologists, radiologists and pathologists. Hepatic resection including the caudate lobe is often performed in order to obtain microscopic tumor-free margins and curative resection (R0). Biliary drainage and treatment of cholangitis is mandatory before surgery in order to improve the surgical outcome. Surgical treatment is characterized by high technical difficulties, and better results can be achieved by hepatobiliary surgical teams.</p>\",\"PeriodicalId\":10182,\"journal\":{\"name\":\"Chirurgie; memoires de l'Academie de chirurgie\",\"volume\":\"124 2\",\"pages\":\"132-9; discussion 139-40\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1999-04-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Chirurgie; memoires de l'Academie de chirurgie\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1016/s0001-4001(99)80055-5\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Chirurgie; memoires de l'Academie de chirurgie","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/s0001-4001(99)80055-5","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
研究目的:克拉特皮瘤是一种罕见的肿瘤。预后仍然较差,只有手术后才能长期生存,是治疗的首选。本研究的目的是报告15例手术切除的结果,并通过文献分析,强调肝门部胆管癌手术治疗的进展。患者与方法:1990 ~ 1998年对27例克拉特金肿瘤患者进行了观察。8名女性和7名男性接受了手术切除。平均年龄59岁。13例(48%)患者行根治性切除(7例肝门切除(HR), 5例肝门切除联合肝部分切除(PH), 1例肝门+肝部分切除合并门静脉切除)。2例患者行姑息性切除和手术引流。结果:1例院内死亡发生在肝切除术合并门静脉切除术后(6.6%)。术后发病率为40%。定期对患者进行随访。研究期间,10例患者死亡,5例患者存活。根治性切除后1年、2年和3年生存率分别为84%、54%和34%。中位生存期为28.5个月。由于患者数量少,淋巴结受累在阳性组和阴性组的中位生存期(26.2个月对29.8个月)上没有统计学上的显著差异。肺门切除术后1、2、3和5年的生存率分别为100%、57.1%、28.6%和0%。6例行肝门切除联合肝部分切除术的患者中,4例在术后1、23、29、38个月仍存活。肝切除术增加了死亡率(16% vs 0%)。2例患者成功行姑息性胆道切除及手术引流。结论:积极的手术治疗可提高克拉特金肿瘤患者的生存率。仔细的术前管理必须由包括外科医生、肝病学家、放射科医生和病理学家在内的多学科方法进行。包括尾状叶在内的肝切除通常是为了获得显微镜下的无肿瘤边缘和治愈性切除(R0)。术前必须进行胆道引流和胆管炎治疗,以提高手术效果。手术治疗技术难度高,肝胆外科团队治疗效果较好。
Study aim: Klatskin tumors are rare. Prognosis is still poor, and long term survival can be expected only after surgery, which is the treatment of choice. The aim of this study is to report the results of 15 resected cases and, by analysis of the literature, to emphasize the progress of the surgical treatment in hilar cholangiocarcinoma.
Patients and methods: Between 1990 and 1998, 27 patients affected by Klatskin tumor were observed. Eight women and seven men underwent surgical resection. The mean age was 59 years. Thirteen patients (48%) had curative resection (7 hilar resection (HR), 5 HR combined with partial hepatectomy (PH) and 1 HR + PH with portal vein resection). Two patients had palliative resection and surgical drainage.
Results: One in-hospital death occurred right after hepatectomy with portal vein resection (6.6%). Postoperative morbidity was 40%. Patients were regularly followed. Ten patients died and 5 were alive at the time of this study. The 1, 2 and 3-year survival after a curative resection was 84%, 54% and 34%. The median survival was 28.5 months. Lymph node involvement did not show a statistically significant difference on median survival between the positive group and the negative group (26.2 vs 29.8 months) because of the small number of patients. Survival after hilar resection at 1, 2, 3, and 5 years was 100%, 57.1%, 28.6% and 0%. Four out of the 6 patients who underwent hilar resection combined with partial hepatectomy were still alive 1, 23, 29, 38 months after resection. Hepatectomy increased mortality (16% vs 0%). Palliative biliary resection and surgical drainage were successfully performed in 2 patients.
Conclusion: Aggressive surgical treatment of Klatskin tumor can improve the survival of patients. Careful pre-operative management has to be carried out by a multidisciplinary approach including surgeons, hepatologists, radiologists and pathologists. Hepatic resection including the caudate lobe is often performed in order to obtain microscopic tumor-free margins and curative resection (R0). Biliary drainage and treatment of cholangitis is mandatory before surgery in order to improve the surgical outcome. Surgical treatment is characterized by high technical difficulties, and better results can be achieved by hepatobiliary surgical teams.